NEU 2.99% $20.10 neuren pharmaceuticals limited

I guess the US$7.3 billion enterprise value of this acquisition...

  1. 43 Posts.
    lightbulb Created with Sketch. 35
    I guess the US$7.3 billion enterprise value of this acquisition implies that Acadia’s global rights for Daybue are worth the same, meaning Acadia is worth $44.90 per share in a takeout for its Daybue rights, excluding the rest of its pipeline. Acadia is now trading at or about US$28.30. What takeout value can be interpolated for Neuren from this acquisition? Probably too soon to tell prior to impending phase 2 results.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.10
Change
-0.620(2.99%)
Mkt cap ! $2.569B
Open High Low Value Volume
$20.41 $20.45 $19.92 $5.947M 296.0K

Buyers (Bids)

No. Vol. Price($)
1 999 $20.10
 

Sellers (Offers)

Price($) Vol. No.
$20.19 10 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.